Advertisement

Ads Placeholder
Loading...

Ono Pharmaceutical Co., Ltd.

OPHLY•PNK
Healthcare
Drug Manufacturers - General
$5.26
$-0.03(-0.57%)
U.S. Market is Open • 15:41

Ono Pharmaceutical Co., Ltd. (OPHLY) Stock Overview

Explore Ono Pharmaceutical Co., Ltd.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap7.5B
P/E Ratio18.78
EPS (TTM)$0.23
ROE0.08%
Fundamental Analysis

AI Price Forecasts

1 Month$6.06
3 Months$6.30
1 Year Target$5.61

OPHLY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Ono Pharmaceutical Co., Ltd. (OPHLY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 57.06, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $5.61.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 18.78 and a market capitalization of 7.5B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
1.54%
1-Month Change
2.12%
3-Month Change
16.26%
6-Month Change
39.21%
Year-to-Date (YTD) Change
16.26%
1-Year Change
52.45%
3-Year Change
-23.88%
5-Year Change
-38.52%
All-Time (Max) Change
42.17%

Contact Information

https://www.ono-pharma.com
81 6 6263 5670
8-2, Kyutaromachi 1-chome, Osaka, NaN, 541-8564

Company Facts

38,530 Employees
IPO DateOct 2, 2012
CountryJP
Actively Trading

Frequently Asked Questions